Reata Pharmaceuticals, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Irving TX United States (2002)

Organization Overview

First Clinical Trial
2005
NCT00526812
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Reata Pharmaceuticals, Inc.